Skin :: Vitamin D by sunlight may protect the skin
Brief periods of unprotected exposure to the sun are found good for skin, revealed by researchers in a study published in this week’s Nature Immunology.
Vitamin D
Prostate Cancer :: Sunshine pill for prostate cancer in 2009
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
Chemotherapy :: Monitor bone health during chemotherapy
In laboratory tests on mice, researchers found that a medication often used to reduce toxic side effects of chemotherapy induced bone loss and helped tumors grow in bone. So the researchers at Washington University School of Medicine in St. Louis are recommending increased awareness of bone health during cancer treatments.
Osteoporosis :: Proposed FDA claim recognizes role of key nutrients in dairy in reducing osteoporosis risk
The Food and Drug Administration has proposed an amended health claim that would communicate to consumers the value of foods high in calcium and vitamin D for reducing the risk of osteoporosis. The National Dairy Council (NDC) acknowledges and supports the body of scientific evidence that backs the proposed claim, which indicates that a lifestyle that includes a well-balanced diet with adequate calcium and vitamin D, and physical activity, helps reduce the risk of osteoporosis.
Vitamin D :: Vitamin D or Boniva, ibandronate reduces bone loss
It appears that alcohol-induced bone loss resulting from excessive binge-alcohol drinking can be prevented by vitamin D or the anti-osteoporosis drug Boniva? (ibandronate), a Loyola University Health System study shows.
Osteoporosis :: PBS extension to benefit osteoporosis patients
The Australian Government has expanded eligibility for the osteoporosis medication alendronate under the Pharmaceutical Benefits Scheme (PBS).
Vitamin D :: Vitamin D lowers multiple sclerosis risk
New research suggests that having higher circulating levels of vitamin D is associated with a reduced risk for multiple sclerosis, although this relationship was not seen for black and Hispanic individuals, according to a study in the Dec. 20 issue of JAMA.
Fosrenol data show evidence of trends towards improved bone formation in CKD stage 5 patients
Treatment with the phosphate binder FOSRENOL(R) (lanthanum carbonate) was associated with slight improvements in bone formation in chronic kidney disease (CKD) Stage 5 patients with hyperphosphatemia (high phosphorus levels in the blood), according to long-term (two-year) data presented at the American Society of Nephrology (ASN) meeting. Additional studies presented at ASN document the efficacy and safety of the reformulated and higher-dose FOSRENOL tablets.
Osteoporosis :: Osteoporosis Risk and Nutrition Awareness
IOF survey shows good general knowledge of nutrition and bone health but confusion about vitamin D; half unaware that osteoporosis is more common amongst women than breast cancer
Osteoporosis :: Reduce risk of osteoporosis – Dairy Council of California
Osteoporosis, a disease characterized by low bone mass that often leads to fractures of the hip, spine and wrist, affects more than 5 million Californians, most of whom are women.(1) In observation of World Osteoporosis Day on October 20, Dairy Council of California offers tips to help women and their families reduce their risk of osteoporosis throughout their lifetimes by eating a healthy diet rich in calcium and other bone-building nutrients, and participating in weight-bearing cardiovascular activities.